News / Health

Study: Drug Preserves Fertility in Younger Women With Cancer

Christy Wolford, a breast cancer survivor, had her ovaries suppressed during cancer treatment and she has had three boys since treatment ended in 2006. She holds son Lucas, 2, as her other children play in the background  in Fort Collins, Colo., May 29, 2014.
Christy Wolford, a breast cancer survivor, had her ovaries suppressed during cancer treatment and she has had three boys since treatment ended in 2006. She holds son Lucas, 2, as her other children play in the background in Fort Collins, Colo., May 29, 2014.
VOA News
A new treatment approach may help thousands of women with early-stage breast cancer avoid premature menopause and preserve their ability to have children, U.S. researchers said.

A study, presented at the annual meeting of American Society of Clinical Oncology (ASCO) in Chicago, showed that women who received AstraZeneca PLC's drug goserelin along with chemotherapy were 64 percent less likely to develop premature menopause than women who had chemotherapy alone. They were also more likely to have successful pregnancies, and the treatment appeared to improve survival.

Chemotherapy often causes premature ovarian failure, or early menopause. Doctors think that active ovaries are more susceptible to chemo damage, and that making the ovaries go dormant and stopping a woman's monthly cycles might help shield them from harm. It might even improve survival, a study found.

The study involved 257 women around the world under age 50 with breast cancers whose growth is not fueled by estrogen. They all had standard chemo and half also had monthly shots of goserelin, a drug to lower estrogen and temporarily put the ovaries at rest. Its main side effects are menopause symptoms - hot flashes and vaginal dryness, the AP reported.

Doctors then tracked the women to see how the treatments affected fertility.

Study results

After two years, full results were available on 135 participants. Only 8 percent of those given the shots became menopausal versus 22 percent of the others who didn't get them. There were 22 pregnancies in the drug group versus 12 in the other one.

That's encouraging, but firm comparisons can't really be made because not all women may have been trying to conceive, and other factors such as a partner's fertility play a role, the AP reported.

Still, "the difference was enough that in spite of all the limitations in the study, we were pretty convincingly able to see an effect," said the study's leader, Dr. Halle Moore of the Cleveland Clinic, according to the AP.

The benefits go beyond preserving fertility, said Dr. Kathy Albain, a breast cancer specialist at Chicago's Loyola University and one of the study leaders.

"Some women don't care about having children" after breast cancer, but would like to avoid "being jolted into early menopause" by chemo treatment, she said.

About a quarter of breast cancers occur in women under 50, affecting some 40,000 to 50,000 women each year. Unlike natural menopause, which occurs gradually, chemotherapy can suddenly throw a woman into full-blown menopause. In about half of these women, this condition is permanent, eliminating the chance for a future pregnancy.

"This is the first time anything has been shown to prevent this," said Albain. "I think these findings are going to change our clinical practice."

During the study's design, researchers were concerned that adding the hormone treatment might hurt the women's breast cancer treatment, Reuters reported.

But the results suggest women who got goserelin were 50 percent more likely to be alive four years after starting treatment compared with those receiving the standard therapy.

National Cancer Day

To mark National Cancer Day, the American Cancer Society noted that there are 14.5 million cancer survivors in the United States and that number is expected to grow to 19 million over the next decade.

More cancers are cured, more people are living longer with the disease and people are living longer in general, which boosts the number of cases and survivors because the risk of developing cancer rises with age, the American Cancer Society noted in a report by the AP.

The report came on the third day of the annual meeting of ASCO, the world's largest group of specialists who treat cancer. This year's event, ASCO's 50th, brings together 30,000 doctors, researchers and pharmaceutical agents from around the world.

"Scientifically, the field of oncology has never been more exciting," said Clifford Hudis, president of ASCO, according to the French news agency AFP.

Progess made

Hudis cited new targeted therapies that take aim at the cellular functions of tumors, leading to progress against some difficult to treat cancers. Also, immunotherapy is an exciting field that uses a patient's own immune system to attack tumors, and is showing promise against melanoma, leukemia, and a handful of other cancers.

"We have made incredible progress in 50 years," said Jyoti Patel, a cancer specialist at Northwestern University, according to AFP

"The scientific breakthroughs in cancer are occurring at a breathtaking pace and are being translated into new drugs and devices that benefit patients more quickly than ever before," said Richard Schilsky, chief medical officer of ASCO, AFP reported.

However, he warned that this progress is in jeopardy due to a shortage of research funds, particularly from the National Institutes of Health, the largest government funder of US scientific research wich in 2013 had a budget of $28.9 billion.

Some information for this report provided by Reuters, AFP and AP.

You May Like

Is Air Travel Safe?

Aviation expert says despite tragic losses of Malaysian Airlines flights 370 and 17, industry experienced lowest fatality rate in recorded history last year More

Multimedia 100 Days Later, Nigerian Girls Still Held

Activists holding rallies in Nigeria and several other countries to mark 100th day of captivity for more than 200 schoolgirls being held by Boko Haram More

Chocolate Too Bitter? Swap Sugar for Mushrooms

US food technology company develops fermentation process using mushrooms to reduce bitterness in cocoa beans, believes it will cut sugar content in candy More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
US Carriers Suspend Travel to Israeli
X
Carolyn Presutti
July 23, 2014 1:21 AM
The United States is prohibiting American carriers from flying to Israel's airport in Tel Aviv for 24 hours, because of rising violence between Israel and Hamas militants. The action was announced on Tuesday, after a rocket fired by Hamas militants in the Gaza Strip landed near the airport. As VOA's Carolyn Presutti tells us, international officials soon may have to determine which combat zones are too dangerous for commercial flights.
Video

Video US Carriers Suspend Travel to Israel

The United States is prohibiting American carriers from flying to Israel's airport in Tel Aviv for 24 hours, because of rising violence between Israel and Hamas militants. The action was announced on Tuesday, after a rocket fired by Hamas militants in the Gaza Strip landed near the airport. As VOA's Carolyn Presutti tells us, international officials soon may have to determine which combat zones are too dangerous for commercial flights.
Video

Video NASA Focuses on Earth-Like Planets

For decades, looking for life elsewhere in the universe meant listening for signals that could be from distant civilizations. But recent breakthroughs in space technology refocused some of that effort toward finding planets that may harbor life, even in its primitive form. VOA’s George Putic reports on a recent panel discussion at NASA’s headquarters, in Washington.
Video

Video IAEA: Iran Turns its Enriched Uranium Into Less Harmful Form

Iran has converted its stockpiles of enriched uranium into a less dangerous form that is more difficult to use for nuclear weapons, according to the United Nations’ Atomic Energy Agency. The move complies with an interim deal reached with Western powers on Iran's nuclear program last year, in exchange for easing of sanctions. Henry Ridgwell reports for VOA from London.
Video

Video Relic of Saint Draws Catholics Worried About Immigration Issue

A Roman Catholic saint who is a figure of devotion for those crossing the border into the United States is attracting believers concerned about the plight of undocumented immigrants. Mike O'Sullivan reports from Los Angeles, where a relic of Saint Toribio has drawn thousands to local churches.
Video

Video US Awards Medal of Honor for Heroics in Bloodiest of Afghan Battles

U.S. combat troops are withdrawing from Afghanistan, on pace to leave the country by the end of this year. But on Monday, U.S. President Barack Obama took time to honor a soldier whose actions while under fire in Afghanistan earned him the Medal of Honor. VOA's Jeff Seldin has more from the Pentagon.
Video

Video Ukraine Rebels Surrender MH17 Black Boxes

After days of negotiations, a senior separatist leader handed over two black boxes from an airliner downed over eastern Ukraine to Malaysian experts early Tuesday. While on Monday, the U.N. Security Council unanimously demanded that armed groups controlling the crash site allow safe and unrestricted access to the wreckage.
Video

Video In Cambodia, HIV Diagnosis Brings Deadly Shame

Although HIV/AIDS is now a treatable condition, a positive diagnosis is still a life altering experience. In Cambodia, people living with HIV are often disowned by friends, family and the community. This humiliation can be unbearable. We bring you one Cambodian woman’s struggle to overcome a life tragedy and her own HIV positive diagnosis.
Video

Video Nature of Space Exploration Enters New Age

Forty-five years ago this month, the first humans walked on the moon. It was during an era of the space race between the United States and the Soviet Union. World politics have changed since then and -- as Elizabeth Lee reports -- so has the nature of space exploration.

AppleAndroid